Is TBGNF or SBUX a better dividend investment in 2026?

TBGNF currently yields 1176.47% with a 5% 5-year dividend growth rate. SBUX yields 2.75% with 5% growth. The better choice depends on your goal: TBGNF offers higher current income.

What is the dividend yield difference between TBGNF and SBUX?

TBGNF has a forward dividend yield of 1176.47% ($2.00/share annually). SBUX yields 2.75% ($2.46/share annually). The yield gap is 1173.72 percentage points.

Home › Compare › TBGNF vs SBUX

TBGNF vs SBUX: Dividend Comparison 2026

TBGNF yields 1176.47% · SBUX yields 2.75%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TBGNF wins by $78814195.04M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TBGNF

● Live price

1176.47%

Share price

$0.17

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$78814195.20M

Annual income

$67,523,701,253,088.38

Full TBGNF calculator →

SBUX

● Live price

2.75%

Share price

$89.59

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$157.5K

Annual income

$65,840.13

Full SBUX calculator →

Portfolio growth — TBGNF vs SBUX

📍 TBGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TBGNF	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TBGNF + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TBGNF pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBGNF

Annual income on $10K today (after 15% tax)

$100,000.00/yr

After 10yr DRIP, annual income (after tax)

$57,395,146,065,125.13/yr

SBUX

Annual income on $10K today (after 15% tax)

$233.40/yr

After 10yr DRIP, annual income (after tax)

$55,964.11/yr

At 15% tax rate, TBGNF beats the other by $57,395,146,009,161.02/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBGNF + SBUX for your $10,000?

TBGNF: 50%SBUX: 50%

100% SBUX50/50100% TBGNF

Portfolio after 10yr

$39407097.68M

Annual income

$33,761,850,659,464.25/yr

Blended yield

85.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

TBGNF

No analyst data

Altman Z

-23.0

Piotroski

2/9

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+16.1% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBGNF buys

SBUX buys

Politician	Chamber	Ticker	Type	Amount	Date
Shelley Moore Capito	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-28
Shelley Moore Capito	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-28
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Dan Newhouse	🏢 House	$SBUX	▼ Sell	$1,001 - $15,000	2025-12-11
Ro Khanna	🏢 House	$SBUX	▼ Sell	$15,001 - $50,000	2025-10-07
Ro Khanna	🏢 House	$SBUX	▲ Buy	$15,001 - $50,000	2025-09-29
Ro Khanna	🏢 House	$SBUX	▼ Sell	$15,001 - $50,000	2025-08-26

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTBGNFSBUX

Forward yield	1176.47% ✓	2.75%
Annual dividend / share	$2.00	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$78814195.20M ✓	$157.5K
Annual income after 10y	$67,523,701,253,088.38 ✓	$65,840.13
Total dividends collected	$77969765.27M ✓	$127.5K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: TBGNF vs SBUX ($10,000, DRIP)

Year	TBGNF Portfolio	TBGNF Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$128,347	$117,647.06	$11,107	$407.21	+$117.2K → TBGNF
2	$1,548,514	$1,411,182.61	$12,512	$626.87	+$1.54M → TBGNF
3	$17,569,052	$15,912,142.01	$14,366	$978.69	+$17.55M → TBGNF
4	$187,523,354	$168,724,468.35	$16,929	$1,557.50	+$187.51M → TBGNF
5	$1,883,716,681	$1,683,066,692.55	$20,658	$2,543.80	+$1883.70M → TBGNF
6	$17,816,329,317	$15,800,752,468.33	$26,406	$4,302.22	+$17816.30M → TBGNF
7	$158,731,384,105	$139,667,911,735.60	$35,877	$7,622.00	+$158731.35M → TBGNF
8	$1,332,782,916,056	$1,162,940,335,063.89	$52,741	$14,352.64	+$1332782.86M → TBGNF
9	$10,551,863,503,163	$9,125,785,782,982.70	$85,676	$29,243.03	+$10551863.42M → TBGNF
10	$78,814,195,201,473	$67,523,701,253,088.38	$157,513	$65,840.13	+$78814195.04M → TBGNF

TBGNF vs SBUX: Complete Analysis 2026

TBGNF — Stock

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Full TBGNF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this TBGNF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBGNF vs SCHD TBGNF vs JEPI TBGNF vs O TBGNF vs KO TBGNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.